GLS and neoplasm: MYC specifically activates the expression of glutamine transporter and glutaminase in tumors, thereby regulating the reprogramming of glutamine metabolism in tumors [30, 72, 73].At the same time, MYC also regulates the expression of PD-L1 and CD47 in the tumor cells.